Skip to main content

Preterm Labor

2
Pipeline Programs
6
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Pediatrix Therapeutics
Pediatrix TherapeuticsChina - Shanghai
1 program
1
BetamethasonePhase 31 trial
Active Trials
NCT02351310Withdrawn0Est. Nov 2015
Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
1
Fish OilPhase 21 trial
Establishment of a Perinatal Database and a Bank of Biological MaterialsN/A1 trial
Active Trials
NCT00339235Completed30,570Est. Nov 2016
NCT04417595Active Not Recruiting400Est. Jan 2026
Biocorp
BiocorpFrance - Issoire
1 program
Electrical Uterine PacemakerN/A1 trial
Active Trials
NCT02983240Suspended110Est. Jan 2026
Hologic
HologicMARLBOROUGH, MA
1 program
Screening To Obviate Preterm BirthN/A1 trial
Active Trials
NCT01868308Completed589Est. Jun 2015
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
fetal lung elastography measurementN/A1 trial
Active Trials
NCT06168149UnknownEst. Mar 2024
IQVIA
IQVIADURHAM, NC
1 program
OBE022PHASE_21 trial
Active Trials
NCT03369262Unknown115Est. Aug 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pediatrix TherapeuticsBetamethasone
Human BioSciencesFish Oil
IQVIAOBE022
City Therapeuticsfetal lung elastography measurement
BiocorpElectrical Uterine Pacemaker
HologicScreening To Obviate Preterm Birth
Human BioSciencesEstablishment of a Perinatal Database and a Bank of Biological Materials

Clinical Trials (7)

Total enrollment: 31,784 patients across 7 trials

NCT02351310Pediatrix TherapeuticsBetamethasone

Effectiveness of ACS in Extreme Preemies

Start: Nov 2015Est. completion: Nov 20150
Phase 3Withdrawn
NCT04417595Human BioSciencesFish Oil

Omega-3 Fatty Acids for Smoking Cessation in Pregnancy

Start: Nov 2020Est. completion: Jan 2026400 patients
Phase 2Active Not Recruiting
NCT03369262IQVIAOBE022

PoC Study of OBE022 in Threatened Preterm Labour

Start: Jan 2018Est. completion: Aug 2022115 patients
Phase 2Unknown
NCT06168149City Therapeuticsfetal lung elastography measurement

The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor

Start: Sep 2023Est. completion: Mar 2024
N/AUnknown
NCT02983240BiocorpElectrical Uterine Pacemaker

Electrical Inhibition of Human Preterm Contractions

Start: Mar 2017Est. completion: Jan 2026110 patients
N/ASuspended
NCT01868308HologicScreening To Obviate Preterm Birth

Screening To Obviate Preterm Birth

Start: Jan 2013Est. completion: Jun 2015589 patients
N/ACompleted
NCT00339235Human BioSciencesEstablishment of a Perinatal Database and a Bank of Biological Materials

Establishment of a Perinatal Database and a Bank of Biological Materials

Start: Jan 1998Est. completion: Nov 201630,570 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.